Literature DB >> 26142108

Update and Review: Cystic Fibrosis.

T Brown1, E L Schwind.   

Abstract

Cystic fibrosis (CF) is one of the most commonly inherited recessive disorders in U.S. Caucasians, with a carrier frequency of approximately 1 in 29. Genetic counseling and CF mutation analysis has traditionally been offered to the affected patient and his/her extended family, in keeping with policy statements from professional organizations (ASHG, NSGC, ACOG). The target population for CF testing and counseling may be evolving after the release of the 1997 National Institutes of Health Consensus Statement, Genetic Testing for Cystic Fibrosis, which recommends that CF screening be offered to all preconceptional and pregnant couples. Genetic counseling for CF is complicated by reports of polymorphisms in the CF gene that are associated with symptoms that do not meet the diagnostic criteria for CF, such as bilateral congenital absence of the vas deferens, bronchiectasis, and idiopathic pancreatitis. To aid genetic counselors with these issues, this review explores the symptoms of CF, patient management, gene function, genetics, genotype/phenotype correlation, and genetic counseling issues.

Entities:  

Year:  1999        PMID: 26142108     DOI: 10.1023/A:1022853822424

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  152 in total

1.  Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease.

Authors:  K J Friedman; R A Heim; M R Knowles; L M Silverman
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

2.  CFTR gene variant IVS8-5T in disseminated bronchiectasis.

Authors:  P F Pignatti; C Bombieri; M Benetazzo; A Casartelli; E Trabetti; L S Gilè; L C Martinati; A L Boner; M Luisetti
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

3.  A cost-effectiveness analysis of prenatal carrier screening for cystic fibrosis.

Authors:  A M Vintzileos; C V Ananth; J C Smulian; A J Fisher; D Day-Salvatore; T Beazoglou
Journal:  Obstet Gynecol       Date:  1998-04       Impact factor: 7.661

4.  Cystic fibrosis in adolescents and adults.

Authors:  P Mitchell-Heggs; M Mearns; J C Batten
Journal:  Q J Med       Date:  1976-07

5.  Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management.

Authors:  J M Dicke; J P Crane
Journal:  Obstet Gynecol       Date:  1992-11       Impact factor: 7.661

6.  Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus.

Authors:  A Hamosh; T M King; B J Rosenstein; M Corey; H Levison; P Durie; L C Tsui; I McIntosh; M Keston; D J Brock
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

7.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.

Authors:  E S Tambor; B A Bernhardt; G A Chase; R R Faden; G Geller; K J Hofman; N A Holtzman
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

8.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  A child with cystic fibrosis: II. Subsequent family planning decisions, reproduction and use of prenatal diagnosis.

Authors:  G Evers-Kiebooms; L Denayer; H Van den Berghe
Journal:  Clin Genet       Date:  1990-03       Impact factor: 4.438

Review 10.  Therapies aimed at airway inflammation in cystic fibrosis.

Authors:  M W Konstan
Journal:  Clin Chest Med       Date:  1998-09       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.